MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Cardiac 123I-MIBG Scintigraphy, olfactory testing and transcranial sonography for differentiating between Parkinson’s disease and atypical parkinsonian syndromes during the early stage

    h. fujita, K. Suzuki, A. Numao, Y. Watanabe, T. Uchiyama, T. Miyamoto, M. Miyamoto, T. Kadowaki, K. Hirata (Shimotsuga-gun, Japan)

    Objective: To evaluate the utility of the combined use of cardiac metaiodobenzylguanidine (MIBG) scintigraphy, olfactory testing, and substantia nigra (SN) hyperechogenicity on transcranial sonography (TCS)…
  • 2017 International Congress

    Post-movement beta rebound inhibits future movement

    E. Rhodes, A. Kharko, W. Gaetz, S. Hall (Plymouth, United Kingdom)

    Objective: To evaluate the potential inhibitory effect of post-movement beta rebound (PMBR) on future movement production. Background: Changes in the cortical power of beta oscillations within the…
  • 2017 International Congress

    Structural brain abnormalities associated with preclinical cognitive impairment in Idiopathic Parkinson’s Disease.

    C. Lambert, O. Williams, L. Ricciardi, F. Morgante, T. Barrick, M. Edwards (London, United Kingdom)

    Objective: Using the Progressive Parkinson’s Initiative (PPMI) data, clinical and structural differences between individuals destined to develop PD cognitive impairment was defined. Background: Cognitive dysfunction…
  • 2017 International Congress

    Multicenter Validation of Disease- related Parkinson’s disease pattern with Resting State functional MRI

    K. Schindlbeck, A. Vo, Y. Ma, S. Peng, K. Poston, H. Hurtig, N. Dahodwala, D. Eidelberg (Manhasset, NY, USA)

    Objective: To validate Parkinson’s Disease-related network topography characterized with resting-state functional MRI (rs-fMRI) in two multicenter based cohorts of idiopathic Parkinson’s disease (IPD) patients.  Background:…
  • 2017 International Congress

    In vivo mapping of nigro-striatal dopamine transporter (DAT) availability in early Parkinson´s disease patients using [18F]FE-PE2I and high-resolution positron emission tomography.

    P. Fazio, P. Svenningsson, Z. Cselenyi, C. Halldin, L. Farde, A. Varrone (Stockholm, Sweden)

    Objective: The objective of the present work was to evaluate in vivo with high resolution positron emission tomography (PET), the relative loss of the dopamine…
  • 2017 International Congress

    Olfactory Impairment in Parkinson’s Disease and White Matter Abnormalities in Central Olfactory Areas

    S. Sobhani, M. Aarabi (Tehran, Islamic Republic of Iran)

    Objective: To determine white matter abnormalities in PD patients with various degrees of olfactory impairment. Background: Neuroimaging results of PD brain based on diffusion tensor…
  • 2017 International Congress

    Pathway Selective Deep Brain Stimulation Derived from Patient-Specific Models

    K. Gunalan, B. Howell, R. Patriat, Y. Duchin, G. Sapiro, N. Harel, C. McIntyre (Cleveland, OH, USA)

    Objective: The goal of this work is to quantify the specific pathways directly activated by clinical DBS settings. Background: Deep brain stimulation (DBS) of the…
  • 2017 International Congress

    Assessment of substantia nigra degeneration with magnetic resonance and transcranial ultrasonography

    C. Prieto, V. Suárez, C. Ordás, B. Venegas, R. Cazorla, A. Vinagre (Valdemoro, Spain)

    Objective: Our objective was to assess both exploration techniques in patients with initial IPD and verify the concordance of the findings, thus positioning them as…
  • 2017 International Congress

    Changes in saccade performance with oculomotor task repetition in neurological disorders

    Y. Terao, H. Fukuda, S.-i. Tokushige, S. Inomata-Terada, Y. Ugawa (Tokyo, Japan)

    Objective: To investigate short-term changes in saccade performance associated with repeated performance of oculomotor tasks in various neurological disorders and to elucidate the underlying neural…
  • 2017 International Congress

    Two ethnic clusters with Huntington’s disease in Israel – The case of Mountain Jews and Karaites

    J. Zitser, A. Thaler, N. Inbar, S. Naor, N. Giladi, T. Gurevich (Tel Aviv, Israel)

    Objective: To Assess frequencies of Huntington disease among different Israeli sub-populations Background: Worldwide prevalence estimates of Huntington's disease (HD) vary widely with no reliable information…
  • « Previous Page
  • 1
  • …
  • 27
  • 28
  • 29
  • 30
  • 31
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley